Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics TechnologiesWednesday, 18 May 2011 at 14:15 Add to Calendar ▼2011-05-18 14:15:002011-05-18 15:15:00Europe/LondonMode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics TechnologiesEuropean Biomarkers Summit in LondonLondonSELECTBIOenquiries@selectbiosciences.com Global quantitative phosphoproteomics facilitates detailed mode-of-action analysis of targeted drugs and discovery of regulated protein phosphorylations that can function as response prediction biomarkers for patient stratification. |